February begins pretty much as January left off, with rumblings from the cannabis industry. Monday, investors heard that London, Ontario-based Indiva Limited (TSX-Venture:NDVA) Indiva Limited has received its edibles, extracts and topicals sales licence from Health Canada. This approval enables the firm to deliver extracts, capsules and its portfolio of award-winning edibles to Canadians.
CEO Neil Marotta said simply, "To say we are excited to receive this sales licence is an understatement.
"This sales licence is transformational for Indiva as it allows us to enter new markets and product categories and distribute products nationally. We believe that delivering Canadians truly exceptional and innovative products is our calling and through that passionate pursuit, we can normalize cannabis use. There are millions of Canadians who would like to consume cannabis, but prefer to avoid smoking. Indiva intends to be the solution for those consumers by providing chocolate, sugar, salt, fruit chews and more."
Indiva wants to get going on shipping products to wholesalers throughout the country.
NDVA shares rocketed 2.5 cents, or 10%, by noon EST Monday, to 27.5 cents, on healthy volume of 143,000 shares.
